Progranulin, a new adipokine at the crossroads of metabolic syndrome, diabetes, dyslipidemia and hypertension

Current Pharmaceutical Design

Volumn 23, Issue 10, 2017, Pages 1533-1539

  Korolczuk, Agnieszka ^a   Bełtowski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Adipokines; Atherosclerosis; Endothelial function; Insulin resistance; Nitric oxide; Obesity; Progranulin

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; PROGRANULIN;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CANCER RISK; CARBOHYDRATE METABOLISM; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DYSLIPIDEMIA; GLUCOSE TRANSPORT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INTRAPERITONEAL FAT; METABOLIC SYNDROME X; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; METABOLISM;

ADIPOKINES; ANIMALS; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; METABOLIC SYNDROME;

EID: 85020886444     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612823666170124114524     Document Type: Review

References (63)

1. Chaldakov, GN, Stankulov IS, Hristova M, et al. Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Curr Pharm Des 2003; 9: 1023-31.
2. Fasshauer, M, Blüher M Adipokines in health and disease. Trends Pharmacol Sci 2015; 36, 461-70.
3. Nguyen, A.D, Nguyen TA, Martens LH, Mitic, et al. Progranulin: at the interface of neurodegenerative and metabolic diseases. Trends Endocrinol Metab 2013; 24: 597-606.
4. Shoyab M, McDonald VL, Byles C, et al. Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins. Proc Natl Acad Sci 1990; 87: 7912-6.
5. Bateman A, Belcourt D, Bennett H, et al. Granulins, a novel class of peptide from leukocytes. Biochem Biophys Res Commun 1990;173:1161-8.
6. Qin J, Diaz-Cueto L, Schwarze JE, et al. Effects of progranulin on blastocyst hatching and subsequent adhesion and outgrowth in the mouse. Biol Reprod 2005; 73: 434-42.
7. Suzuki M, Lee HC, Kayasuga Y, et al. Roles of progranulin in sexual differentiation of the developing brain and adult neurogenesis. J Reprod Dev 2009; 55: 351-5.
8. He Z, Ong CH, Halper J, Bateman A. Progranulin is a mediator of the wound response. Nat Med 2003; 9: 225-9.
9. Zhu J, Nathan C, Jin W, et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002; 111: 867-78.
10. Kessenbrock K, Fröhlich L, Sixt M, et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest 2008; 118: 2438-47.
11. Tang W, Lu Y, Tian QY, et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 2011; 332: 478-84.
12. Liu CJ. Progranulin: a promising therapeutic target for rheumatoid arthritis. FEBS Lett 2011; 585: 3675-80.
13. Cerezo LA, Kuklová M, Hulejová H, et al. Progranulin is associated with disease activity in patients with rheumatoid arthritis. Mediators Inflamm 2015; 2015:740357.
14. Yamamoto Y, Takemura M, Serrero G, et al. Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis. Inflammation 2014; 37: 1806-13.
15. Chen J, Li S, Shi J, et al. Serum progranulin irrelated with Breg cell levels, but elevated in RA patients, reflecting high disease activity. Rheumatol Int 2016; 36: 359-64.
16. Thurner L, Stöger E, Fadle N, et al. Proinflammatory progranulin antibodies in inflammatory bowel diseases. Dig Dis Sci 2014; 59: 1733-42.
17. Huang K, Chen A, Zhang X, et al. Progranulin is preferentially expressed in patients with psoriasis vulgaris and protects mice from psoriasis-like skin inflammation. Immunology 2015;145: 279-87
18. Ungurs MJ, Sinden NJ, Stockley RA. Progranulin is a substrate for neutrophil-elastase and proteinase-3 in the airway and its concentration correlates with mediators of airway inflammation in COPD. Am J Physiol Lung Cell Mol Physiol 2014; 306: L80-7.
19. Tanaka A, Tsukamoto H, Mitoma H, et al. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Arthritis Res Ther 2012; 14: R244.
20. Qiu F, Song L, Ding F, et al. Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus. Diagn Pathol 2013; 8: 88.
21. Ichimura Y, Asano Y, Akamata K, et al. Progranulin overproduction due to Fli-1 deficiency contributes to the resistance of dermal fibroblasts to tumor necrosis factor in systemic sclerosis. Arthritis Rheumatol 2015; 67: 3245-55.
22. +regulatory T cells. Immunology 2014; 142: 193-201.
23. Wei F, Zhang Y, Zhao W, et al. Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions. PLoS One 2014; 9: e112110.
24. Tao J, Ji F, Wang F, et al. Neuroprotective effects of progranulin in ischemic mice. Brain Res 2012; 1436: 130-6.
25. Egashira Y, Suzuki Y, Azuma Y, et al. The growth factor progranulin attenuates neuronal injury induced by cerebral ischemiareperfusion through the suppression of neutrophil recruitment. J Neuroinflam 2013; 10: 105.
26. Jackman K, Kahles T, Lane D, et al. Progranulin deficiency promotes post-ischemic blood-brain barrier disruption. J Neurosci 2013; 33: 19579-89.
27. Kanazawa M, Kawamura K, Takahashi T, et al. Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke. Brain 2015; 138: 1932-48.
28. Zhou M, Tang W, Fu Y, et al. Progranulin protects against renal ischemia/reperfusion injury in mice. Kidney Int 2015; 87: 918-29.
29. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916-9.
30. Xu J, Xilouri M, Bruban J, et al. Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling. Neurobiol Aging 2011; 32: 2326.e5-16.
31. Minami SS, Min SW, Krabbe G, et al. Progranulin protects against amyloid β deposition and toxicity in Alzheimer’s disease mouse models. Nat Med 2014; 20: 1157-64.
32. Van Kampen JM, Baranowski D, Kay DG. Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson’s disease. PLoS One 2014; 9: e97032.
33. Brouwers N, Sleegers K, Engelborghs S, et al. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology 2008; 71: 656-64.
34. He Z, Bateman A. Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res 1999; 59: 3222-9.
35. Bateman A, Bennett HP. The granulin gene family: from cancer to dementia. Bioessays 2009; 31: 1245-54.
36. Wang BC, Liu H, Talwar A, et al. New discovery rarely runs smooth: an update on progranulin/TNFR interactions. Protein Cell 2015; 6: 792-803.
37. Park B, Buti L, Lee S, et al. Granulin is a soluble cofactor for tolllike receptor 9 signaling. Immunity 2011; 34: 505-13.
38. Matsubara T, Mita A, Minami K, et al. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metab 2012; 15: 38-50.
39. Li H, Zhou B, Liu J, et al. Administration of progranulin (PGRN) triggers ER stress and impairs insulin sensitivity via PERK-eIF2α-dependent manner. Cell Cycle 2015; 14: 1893-907.
40. Liu J, Li H, Zhou B, et al. PGRN induces impaired insulin sensitivity and defective autophagy in hepatic insulin resistance. Mol Endocrinol 2015; 29: 528-41.
41. Zhou B, Li H, Liu J, et al. Progranulin induces adipose insulin resistance and autophagic imbalance via TNFR1 in mice. J Mol Endocrinol 2015; 55: 231-43.
42. Kim HK, Shin MS, Youn BS, et al. Involvement of progranulin in hypothalamic glucose sensing and feeding regulation. Endocrinology 2011; 152: 4672-82.
43. Youn BS, Bang SI, Klöting N, et al. Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes 2009; 58: 627-36.
44. Blüher M, Rudich A, Klöting N, et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012; 35: 342-9.
45. Qu H, Deng H, Hu Z. Plasma progranulin concentrations are increased in patients with type 2 diabetes and obesity and correlated with insulin resistance. Mediators Inflamm 2013;2013:360190.
46. Priyanka N, Kumari M, Kalra N, et al. Crevicular fluid and serum concentrations of progranulin and high sensitivity CRP in chronic periodontitis and type 2 diabetes. Dis Markers 2013; 35: 389-94.
47. Pradeep AR, Priyanka N, Prasad MV, et al. Association of progranulin and high sensitivity CRP concentrations in gingival crevicular fluid and serum in chronic periodontitis subjects with and without obesity. Dis Markers 2012; 33: 207-13.
48. Li H, Zhou B, Xu L, et al. Circulating PGRN is significantly associated with systemic insulin sensitivity and autophagic activity in metabolic syndrome. Endocrinology 2014; 155: 3493-507.
49. Tönjes A, Fasshauer M, Kratzsch J, et al. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS One 2010; 5: e13911.
50. Tanaka Y, Takahashi T, Tamori Y. Circulating progranulin level is associated with visceral fat and elevated liver enzymes: significance of serum progranulin as a useful marker for liver dysfunction. Endocr J 2014; 61: 1191-6.
51. Todoric J, Handisurya A, Perkmann T, et al. Circulating progranulin levels in women with gestational diabetes mellitus and healthy controls during and after pregnancy. Eur J Endocrinol 2012; 167: 561-7.
52. Ersoy AO, Tokmak A, Ozler S, et al. Are progranulin levels associated with polycystic ovary syndrome and its possible metabolic effects in adolescents and young women? Arch Gynecol Obstet. 2016; 294: 403-9
53. Schlatzer D, Maahs DM, Chance MR, et al. Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care 2012;35: 549-55.
54. Xu L, Zhou B, Li H, et al. Serum levels of progranulin are closely associated with microvascular complication in type 2 Diabetes. Dis Markers 2015; 2015: 357279.
55. Richter J, Focke D, Ebert T, et al. Serum levels of the adipokine progranulin depend on renal function. Diabetes Care 2013; 36: 410-4.
56. Yilmaz Y, Eren F, Yonal O, et al. Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Dis Markers 2011; 31: 205-10.
57. Kazama K, Hoshino K, Kodama T, et al. Adipocytokine, progranulin, augments acetylcholine-induced nitric oxide-mediated relaxation through the increases of cGMP production in rat isolated mesenteric artery. Acta Physiol (Oxf) 2016 doi: 10.1111/apha.12739.
58. Ortega FB, Lavie CJ, Blair SN, et al. Obesity and Cardiovascular Disease. Circ Res 2016; 118: 1752-70.
59. Prieto D, Contreras C, Sánchez A. Endothelial dysfunction, obesity and insulin resistance. Curr Vasc Pharmacol 2014; 12: 412-26.
60. Kojima Y, Ono K, Inoue K, et al. Progranulin expression in advanced human atherosclerotic plaque. Atherosclerosis 2009; 206: 102-8.
61. Yoo HJ, Hwang SY, Hong HC, et al. Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. PLoS One 2013; 8: e55744.
62. Kawase R, Ohama T, Matsuyama A, et al. Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice. Cardiovasc Res 2013; 100: 125-33.
63. Hwang HJ, Jung TW, Hong HC, et al. Progranulin protects vascular endothelium against atherosclerotic inflammatory reaction via Akt/eNOS and nuclear factor-κB pathways. PLoS One 2013; 8: e76679